Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$MYGN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.46 up 87.11% YoY • Reported revenue of $190.7M down -10.51% YoY • Myriad Genetics provides full-year 2026 financial guidance of $770 million to $790 million in revenue and expects an adjusted gross margin percentage in the range of 66% to 67%.

Price since post

Full Details

Advertisement|Remove ads.